OpenURL Connection Search

Select item for more details and to access through your institution.

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study.
Published in:
Cancer Medicine, 2024, v. 13, n. 20, p. 1, doi. 10.1002/cam4.70270
By:
- Liang, Dong;
- Li, Xiaojin;
- Bai, Shenrui;
- Wang, Qiaoli;
- Zeng, Min;
- Feng, Demei;
- Lu, Bo;
- Li, Xiaoqing;
- Sun, Zhiqiang;
- Li, Jianyun;
- Zhou, Huanhuan;
- Zhang, Jialu;
- Chen, Xiaoqin;
- Xia, Zhongjun;
- Liang, Yang;
- Wang, Hua
Publication type:
Article
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer.
Published in:
EMBO Molecular Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.15252/emmm.202114502
By:
- Zhou, Qian;
- Liang, Jinxia;
- Yang, Tong;
- Liu, Jin;
- Li, Bo;
- Li, Yingchang;
- Fan, Zhenzhen;
- Wang, Weida;
- Chen, Wensheng;
- Yuan, Sujing;
- Xu, Meng;
- Xu, Qigui;
- Luan, Zhidong;
- Xia, Zhongjun;
- Zhou, Penghui;
- Huang, Yadong;
- Chen, Liang
Publication type:
Article
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study.
Published in:
American Journal of Hematology, 2023, v. 98, n. 4, p. 571, doi. 10.1002/ajh.26826
By:
- Xu, Wei;
- Zhou, Keshu;
- Wang, Tingyu;
- Yang, Shenmiao;
- Liu, Lihong;
- Hu, Yu;
- Zhang, Wei;
- Ding, Kaiyang;
- Zhou, Jianfeng;
- Gao, Sujun;
- Xu, Bing;
- Zhu, Zunmin;
- Liu, Ting;
- Zhang, Huilai;
- Hu, Jianda;
- Ji, Chunyan;
- Wang, Shunqing;
- Xia, Zhongjun;
- Wang, Xin;
- Li, Yan
Publication type:
Article
Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study.
Published in:
American Journal of Hematology, 2021, v. 96, n. 11, p. 1481, doi. 10.1002/ajh.26335
By:
- Zhang, Yuchen;
- Ma, Shuyun;
- Cai, Jun;
- Yang, Yu;
- Jing, Hongmei;
- Shuang, Yuerong;
- Peng, Zhigang;
- Li, Bingzong;
- Liu, Panpan;
- Xia, Zhongjun;
- Xia, Yi;
- Gao, Yan;
- Chen, Daoguang;
- Lin, Jianyang;
- Li, Qihui;
- Xu, Shenghua;
- Xu, Qingyuan;
- Zhang, Han;
- Huang, Huiqiang;
- Cai, Qingqing
Publication type:
Article
A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience.
Published in:
Cancer Research & Treatment, 2020, v. 52, n. 2, p. 573, doi. 10.4143/crt.2019.542
By:
- Chun Li;
- Zhi-Jun Wuxiao;
- Xiaoqin Chen;
- Guanjun Chen;
- Yue Lu;
- Zhongjun Xia;
- Yang Liang;
- Hua Wang
Publication type:
Article
Cancer pain management in China: current status and practice implications based on the ACHEON survey.
Published in:
Journal of Pain Research, 2017, v. 10, p. 1943, doi. 10.2147/JPR.S128533
By:
- Zhongjun Xia
Publication type:
Article
Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma.
Published in:
2022
By:
- Guan, Jinqiu;
- Sun, Feifei;
- Wang, Juan;
- Huang, Junting;
- Lu, Suying;
- Zhu, Jia;
- Zhu, Xiaoqin;
- Huang, Huiqiang;
- Xia, Zhongjun;
- Que, Yi;
- Cai, Ruiqing;
- Zhen, Zijun;
- Sun, Xiaofei;
- Zhang, Yizhuo
Publication type:
journal article
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study.
Published in:
Annals of Hematology, 2020, v. 99, n. 11, p. 2589, doi. 10.1007/s00277-020-04234-9
By:
- Li, Jing;
- Bao, Li;
- Xia, Zhongjun;
- Wang, Sili;
- Zhou, Xin;
- Ding, Kaiyang;
- Zhang, Wenhao;
- Yang, Wei;
- Li, Bingzong;
- Fu, Chengcheng;
- Chen, Bing;
- Hua, Luoming;
- Wang, Liang;
- Luo, Jun;
- Yang, Yang;
- Xu, Tianhong;
- Wang, Weida;
- Huang, Yun;
- Wu, Guolin;
- Liu, Peng
Publication type:
Article
High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
Published in:
Annals of Hematology, 2015, v. 94, n. 9, p. 1535, doi. 10.1007/s00277-015-2401-4
By:
- Wang, Hua;
- Li, Pengfei;
- Wang, Liang;
- Xia, Zhongjun;
- Huang, HuiQiang;
- Lu, Yue;
- Li, ZhiMing
Publication type:
Article
New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
Published in:
Annals of Hematology, 2014, v. 93, n. 9, p. 1541, doi. 10.1007/s00277-014-2089-x
By:
- Cai, Qingqing;
- Luo, Xiaolin;
- Zhang, Guanrong;
- Huang, Huiqiang;
- Huang, Hui;
- Lin, Tongyu;
- Jiang, Wenqi;
- Xia, Zhongjun;
- Young, Ken
Publication type:
Article
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.
Published in:
2016
By:
- Yan Sun;
- Ying Cheng;
- Xuezhi Hao;
- Jie Wang;
- Chengping Hu;
- Baohui Han;
- Xiaoqing Liu;
- Li Zhang;
- Huiping Wan;
- Zhongjun Xia;
- Yunpeng Liu;
- Wei Li;
- Mei Hou;
- Helong Zhang;
- Qingyu Xiu;
- Yunzhong Zhu;
- Jifeng Feng;
- Shukui Qin;
- Xiaoyan Luo;
- Sun, Yan
Publication type:
journal article
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming.
Published in:
Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01648-z
By:
- Liang, Yuanzheng;
- He, Haiyan;
- Wang, Weida;
- Wang, Henan;
- Mo, Shaowen;
- Fu, Ruiying;
- Liu, Xindi;
- Song, Qiong;
- Xia, Zhongjun;
- Wang, Liang
Publication type:
Article
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11489-8
By:
- Xia, Zhongjun;
- Leng, Yun;
- Fang, Baijun;
- Liang, Yang;
- Li, Wei;
- Fu, Chengcheng;
- Yang, Linhua;
- Ke, Xiaoyan;
- Jiang, Hua;
- Weng, Jianyu;
- Liu, Li;
- Zhao, Yaozhong;
- Zhang, Xuejun;
- Huang, Zhongxia;
- Liu, Aichun;
- Shi, Qingzhi;
- Gao, Yuhuan;
- Chen, Xiequn;
- Pan, Ling;
- Cai, Zhen
Publication type:
Article
Safety and feasibility analysis of rapid daratumumab infusion in Chinese patients with multiple myeloma.
Published in:
Cancer Medicine, 2024, v. 13, n. 11, p. 1, doi. 10.1002/cam4.7347
By:
- Yin, Xi‐xi;
- Hu, Yueyun;
- Yang, Yusi;
- Zhang, Xinglan;
- Liu, Li;
- Cao, Xi;
- Chen, Jianwen;
- Xia, Zhongjun;
- Wang, Ye
Publication type:
Article
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study.
Published in:
Cancer Medicine, 2022, v. 11, n. 22, p. 4134, doi. 10.1002/cam4.4765
By:
- Zhang, Yuchen;
- Liu, Panpan;
- Cai, Jun;
- Jing, Hongmei;
- Zou, Liqun;
- Huang, Huiqiang;
- Wu, Yuanbin;
- Li, Wenyu;
- Zhong, Liye;
- Jin, Xueli;
- Ye, Xu;
- Feng, Ru;
- Zhang, Huilai;
- Zhang, Liling;
- Lin, Lie;
- Sun, Xiuhua;
- Tian, Yuyang;
- Xia, Zhongjun;
- Li, Zhiming;
- Huang, He
Publication type:
Article
Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study.
Published in:
Cancer Biology & Medicine, 2023, v. 20, n. 1, p. 77, doi. 10.20892/j.issn.2095-3941.2022.0612
By:
- Huishou Fan;
- Weida Wang;
- Ya Zhang;
- Jianxiang Wang;
- Tao Cheng;
- Lugui Qiu;
- Xin Wang;
- Zhongjun Xia;
- Gang An
Publication type:
Article
P-192: Circularly permuted TRAIL (CPT) combined with Thalidomide and Dexamethasone in patients with relapsed/refractory Multiple Myeloma: a randomized, double-blind, placebo-controlled phase 3 study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S143, doi. 10.1016/S2152-2650(21)02319-3
By:
- Wenming Chen;
- Zhongjun Xia;
- Baijun Fang;
- Chengcheng Fu;
- Wei Li;
- Linhua Yang;
- Xiaoyan Ke;
- Hua Jiang;
- Jianyu Weng;
- Li Liu;
- Yaozhong Zhao;
- Xuejun Zhang;
- Aichun Liu;
- Zhongxia Huang;
- Qingzhi Shi;
- Yuhuan Gao;
- Xiequn Chen;
- Ling Pan;
- Zhen Cai;
- Zhao Wang
Publication type:
Article
P-160: Efficacy and safety of induction therapy with IAd versus IRd regimen in fragile elderly patients with newly diagnosed multiple myeloma: results of a prospective multicenter clinical trail.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S123, doi. 10.1016/S2152-2650(21)02287-4
By:
- Li Bao;
- Minqiu Lu;
- Peng Liu;
- Junling Zhuang;
- Mei Zhang;
- Zhongjun Xia;
- Zhenling Li;
- Hongmei Jing;
- Yin Wu;
- Wen ming Chen;
- Hebing Zhou;
- Yuping Gong;
- Rong Fu;
- Zhenyu Yan;
- Wenrong Huang;
- Bin Chu;
- Yutong Wang;
- Yongqing Zhang
Publication type:
Article
A Phase 3 Study of Carfilzomib and Dexamethasone (Kd) in Patients With Relapsed and Refractory Multiple Myeloma (MM) in China.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e267, doi. 10.1016/j.clml.2019.09.441
By:
- Du, Juan;
- Fang, Baijun;
- Li, Jian;
- Jin, Jie;
- Wang, Shunqing;
- Zou, Dehui;
- cai, zhen;
- Wang, Hongxiang;
- Hu, Jianda;
- Li, Wei;
- Fu, Chengcheng;
- Shao, Zonghong;
- Xia, Zhongjun;
- Liu, Peng;
- Niu, Ting;
- Tang, En-Tzu;
- Kimball, Amy;
- Hou, Jian;
- Chen, Wenming
Publication type:
Article
Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma.
Published in:
International Journal of Oncology, 2018, v. 52, n. 5, p. 1528, doi. 10.3892/ijo.2018.4299
By:
- Zhong, Weijie;
- Xu, Xin;
- Zhu, Zhigang;
- Yang, Li;
- Du, Hong;
- Xia, Zhongjun;
- Yuan, Zhaohu;
- Xiong, Huabao;
- Du, Qinghua;
- Wei, Yaming;
- Li, Qingshan
Publication type:
Article
The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
Published in:
PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164210
By:
- Cai, Qingqing;
- Chen, Kailin;
- Chen, Jie;
- Wu, Shaoxu;
- Geng, Qirong;
- Huang, Huiqiang;
- Lin, Tongyu;
- Jiang, Wenqi;
- Xia, Zhongjun;
- Duan, Huaxin;
- Rao, Huilan;
- Yao, Mengfei;
- Hu, Liyang
Publication type:
Article
A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China.
Published in:
International Journal of Hematology, 2021, v. 113, n. 3, p. 422, doi. 10.1007/s12185-020-03044-z
By:
- Du, Juan;
- Fang, Baijun;
- Li, Jian;
- Jin, Jie;
- Wang, Shunqing;
- Zou, Dehui;
- Cai, Zhen;
- Wang, Hongxiang;
- Hu, Jianda;
- Li, Wei;
- Fu, Chengcheng;
- Shao, Zonghong;
- Xia, Zhongjun;
- Liu, Peng;
- Niu, Ting;
- Tang, En-Tzu;
- Kimball, Amy S.;
- Hou, Jian;
- Chen, Wenming
Publication type:
Article
Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
Published in:
2019
By:
- Li, Chun;
- Cai, Xiuyu;
- Chen, Xiaoqin;
- Liang, Yang;
- Xia, Zhongjun;
- Wang, Hua
Publication type:
journal article
A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Published in:
2021
By:
- Cai, Jun;
- Tian, Xiaopeng;
- Ma, Shuyun;
- Zhong, Liye;
- Li, Wenyu;
- Wang, Liang;
- Guo, Linlang;
- Li, Zhihua;
- Wu, Yudan;
- Zhong, Guangzheng;
- Huang, Huiqiang;
- Xia, Zhongjun;
- Xia, Yi;
- Liu, Panpan;
- Su, Ning;
- Fang, Yu;
- Zhang, Yuchen;
- Cai, Qingqing
Publication type:
journal article
Comparison of chemotherapy with or without asparaginase for extranodal nasal NK/T‐cell lymphoma in children and adolescents.
Published in:
Pediatric Blood & Cancer, 2021, v. 68, n. 5, p. 1, doi. 10.1002/pbc.28901
By:
- Zhen, Zijun;
- Huang, Huiqiang;
- Lin, Tongyu;
- Li, Zhiming;
- Zhen, Xi;
- Xia, Zhongjun;
- Zhu, Jia;
- Lu, Suying;
- Sun, Feifei;
- Wang, Juan;
- Huang, Junting;
- Sun, Xiaofei
Publication type:
Article
Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2.
Published in:
Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 6, p. 1495, doi. 10.4103/jcrt.JCRT_782_23
By:
- Jun Wang;
- Liang Shao;
- Jing Liang;
- Qingming Wu;
- Baoli Zhu;
- Qiwen Deng;
- Zelin Liu;
- Liqiong Liu;
- Danyu Wang;
- Zhijian Yu;
- Xiaohua Tan;
- Fuxiang Wang;
- Jingye Meng;
- Xiaojun Xu;
- Zhongjun Xia;
- Zhiming Li;
- Hua Wang;
- Liang Wang;
- Wei Wu;
- Qi Xie
Publication type:
Article
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.
Published in:
2022
By:
- Qiu, Lugui;
- Xia, Zhongjun;
- Fu, Chengcheng;
- Chen, Wenming;
- Chang, Chunkang;
- Fang, Baijun;
- An, Gang;
- Wei, Yongqiang;
- Cai, Zhen;
- Gao, Sujun;
- Weng, Jianyu;
- Chen, Lijuan;
- Jing, Hongmei;
- Li, Fei;
- Liu, Zhuogang;
- Chen, Xiequn;
- Liu, Jing;
- Wang, Aihua;
- Yu, Yang;
- Xiang, Wenxi
Publication type:
journal article
Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Published in:
Oncology Letters, 2016, v. 12, n. 2, p. 825, doi. 10.3892/ol.2016.4691
By:
- HUA WANG;
- PENGFEI LI;
- XINKE ZHANG;
- ZHONGJUN XIA;
- YUE LU;
- HUIQIANG HUANG
Publication type:
Article
Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.772015
By:
- Shang, Yufeng;
- Wang, Weida;
- Liang, Yuxing;
- Kaweme, Natasha Mupeta;
- Wang, Qian;
- Liu, Minghui;
- Chen, Xiaoqin;
- Xia, Zhongjun;
- Zhou, Fuling
Publication type:
Article
A Preliminary Study of Culture Shock and Adaptation Tactics for Overseas Chinese Students --from the Perspective of "American Dreams in China".
Published in:
Theory & Practice in Language Studies (TPLS), 2020, v. 10, n. 3, p. 336, doi. 10.17507/tpls.1003.11
By:
- Zhongjun Xia
Publication type:
Article
Long-term outcomes of different bortezomibbased regimens in Chinese myeloma patients.
Published in:
OncoTargets & Therapy, 2016, v. 9, p. 587, doi. 10.2147/OTT.S97457
By:
- Hua Wang;
- Liang Wang;
- Yue Lu;
- Xiaoqin Chen;
- Qirong Geng;
- Weida Wang;
- Zhongjun Xia
Publication type:
Article
Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy.
Published in:
OncoTargets & Therapy, 2015, v. 8, p. 2589, doi. 10.2147/OTT.S91077
By:
- Hua Wang;
- Liang Wang;
- ZhiJun Wuxiao;
- HuiQiang Huang;
- WenQi Jiang;
- ZhiMing Li;
- Yue Lu;
- ZhongJun Xia
Publication type:
Article
Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors.
Published in:
BMC Cancer, 2010, v. 10, p. 358, doi. 10.1186/1471-2407-10-358
By:
- JiaJia Huang;
- WenQi Jiang;
- RuiHua Xu;
- HuiQiang Huang;
- Yue Lv;
- ZhongJun Xia;
- XiaoFei Sun;
- ZhongZhen Guan;
- TongYu Lin;
- ZhiMing Li
Publication type:
Article

Found: 33